CORRECTED: Teva Copaxone Patent Upheld As Valid By EPO
The European Patent Office has upheld the validity of a patent on Teva Pharmaceutical Industries Ltd.'s multiple sclerosis drug Copaxone in an oral ruling, according to a U.S. Securities and Exchange...To view the full article, register now.
Already a subscriber? Click here to view full article